Naminidil
Alternative Names: BMS 234303; BMS 234303-01Latest Information Update: 17 Jan 2008
At a glance
- Originator Bristol-Myers Squibb
- Class Guanidines; Small molecules; Vasodilators
- Mechanism of Action Potassium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alopecia
Most Recent Events
- 17 Jan 2008 Discontinued - Phase-II for Alopecia in USA (Topical)
- 08 Aug 2001 Phase-II clinical trials for Alopecia in USA (Topical)